logo
Plus   Neg
Share
Email

Pilgrim's Pride Board Approves Appointment Of Jayson Penn As President & CEO

Pilgrim's Pride Corp. (PPC) announced that its Board has approved the appointment of Jayson Penn, current President of Pilgrim's USA, to succeed Bill Lovette as President and CEO. Lovette will remain available to provide strategic advisory services to the company through July 2020. Penn will assume the position of President and CEO immediately.

Penn joined Pilgrim's in March 2011 and has served as Senior Vice President of the Commercial Business Group, Executive Vice President of Sales and Operations and, most recently, as President of Pilgrim's USA. He has also served on the board and the executive committee of the USA Poultry and Egg Export Council and currently serves on the board and executive committee of the National Chicken Council and the board of The World Poultry Foundation.

"The Board's decision is further validation of the Pilgrim's strategy, implemented in 2012, to create a unique, diversified portfolio across multiple geographies, with a focus on key customers and operational excellence, to generate more consistent and higher margins. Jayson has been at the forefront of this strategy and we are confident in his ability to continue to create shareholder value," said Gilberto Tomazoni, Chairman of the Board of Directors.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Tesla Chief Executive Officer Elon Musk has called for a breakup of Amazon after the online retail giant refused to publish an upcoming book about COVID-19. Writer Alex Berenson said on Twitter that Amazon refused to publish his booklet about the coronavirus as it did not comply with the company's guidelines. Berenson is a former New York Times reporter. Two companies have recalled Wintergreen Essential Oil saying the lack of child resistant packaging as required carries the risks of poisoning children, the U.S. Consumer Product Safety Commission stated. Waldo, Wisconsin - based Capstone Holdings LLC is calling back about 2,935 units of Simply Earth Wintergreen Essential Oil that were manufactured in the United States. The U.S. Food and Drug Administration approved Merck & Co. Inc.'s combination antibiotic Recarbrio for the expanded indication in the treatment of adults with hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP). The drug had received initial approval in the U.S. in July 2019 to treat patients with complicated urinary tract infections and complicated intra-abdominal infecti
RELATED NEWS
Follow RTT